APA

de Jong P. H., Hazes J. M., Barendregt P. J., Huisman M., van Zeben D., van der Lubbe P. A., Gerards A. H., de Jager M. H., de Sonnaville P. B., Grillet B. A., Luime J. J. & Weel A. E. (20130306). Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. : Annals of the rheumatic diseases.

Chicago

de Jong P H, Hazes J M, Barendregt P J, Huisman M, van Zeben D, van der Lubbe P A, Gerards A H, de Jager M H, de Sonnaville P B, Grillet B A, Luime J J and Weel A E. 20130306. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. : Annals of the rheumatic diseases.

Harvard

de Jong P. H., Hazes J. M., Barendregt P. J., Huisman M., van Zeben D., van der Lubbe P. A., Gerards A. H., de Jager M. H., de Sonnaville P. B., Grillet B. A., Luime J. J. and Weel A. E. (20130306). Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. : Annals of the rheumatic diseases.

MLA

de Jong P H, Hazes J M, Barendregt P J, Huisman M, van Zeben D, van der Lubbe P A, Gerards A H, de Jager M H, de Sonnaville P B, Grillet B A, Luime J J and Weel A E. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. : Annals of the rheumatic diseases. 20130306.